BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8875229)

  • 21. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
    Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H
    Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained liver-specific transgene expression from the albumin promoter in mice following hydrodynamic plasmid DNA delivery.
    Wooddell CI; Reppen T; Wolff JA; Herweijer H
    J Gene Med; 2008 May; 10(5):551-63. PubMed ID: 18330848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activator protein 1-mediated transcriptional regulation strategy sustains long-term expression of a xenogeneic gene product in vivo: an implication for gene therapy targeting congenital protein deficiencies.
    Sasaki S; Smith JM; Takase K; Okuda K; Ishii N; Takeshita F
    Int J Mol Med; 2006 Aug; 18(2):289-97. PubMed ID: 16820937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo.
    Steinwaerder DS; Lieber A
    Gene Ther; 2000 Apr; 7(7):556-67. PubMed ID: 10819570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
    Ji L; Bouvet M; Price RE; Roth JA; Fang B
    Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct comparison of hepatocyte-specific expression cassettes following adenoviral and nonviral hydrodynamic gene transfer.
    Jacobs F; Snoeys J; Feng Y; Van Craeyveld E; Lievens J; Armentano D; Cheng SH; De Geest B
    Gene Ther; 2008 Apr; 15(8):594-603. PubMed ID: 18288213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
    Latham JP; Searle PF; Mautner V; James ND
    Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression.
    Liu BH; Wang X; Ma YX; Wang S
    Gene Ther; 2004 Jan; 11(1):52-60. PubMed ID: 14681697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancing rAAV vector expression in the lung.
    Virella-Lowell I; Zusman B; Foust K; Loiler S; Conlon T; Song S; Chesnut KA; Ferkol T; Flotte TR
    J Gene Med; 2005 Jul; 7(7):842-50. PubMed ID: 15838934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver.
    Jaffe HA; Danel C; Longenecker G; Metzger M; Setoguchi Y; Rosenfeld MA; Gant TW; Thorgeirsson SS; Stratford-Perricaudet LD; Perricaudet M
    Nat Genet; 1992 Aug; 1(5):372-8. PubMed ID: 1302034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant expression of coagulation factor VIII in hepatic and non-hepatic cell lines stably transduced with third generation lentiviral vectors comprising the minimal factor VIII promoter.
    Picanço V; Heinz S; Bott D; Behrmann M; Covas DT; Seifried E; Tonn T
    Cytotherapy; 2007; 9(8):785-94. PubMed ID: 17917890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient muscle-specific transgene expression after adenovirus-mediated gene transfer in mice using a 1.35 kb muscle creatine kinase promoter/enhancer.
    Larochelle N; Lochmüller H; Zhao J; Jani A; Hallauer P; Hastings KE; Massie B; Prescott S; Petrof BJ; Karpati G; Nalbantoglu J
    Gene Ther; 1997 May; 4(5):465-72. PubMed ID: 9274724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovine adenovirus vectors mediate efficient gene transfer to skeletal muscle.
    Löser P; Hillgenberg M; Arnold W; Both GW; Hofmann C
    Gene Ther; 2000 Sep; 7(17):1491-8. PubMed ID: 11001369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications.
    Casado E; Gomez-Navarro J; Yamamoto M; Adachi Y; Coolidge CJ; Arafat WO; Barker SD; Wang MH; Mahasreshti PJ; Hemminki A; Gonzalez-Baron M; Barnes MN; Pustilnik TB; Siegal GP; Alvarez RD; Curiel DT
    Clin Cancer Res; 2001 Aug; 7(8):2496-504. PubMed ID: 11489832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoters influence the kinetics of transgene expression following adenovector gene delivery.
    Chen P; Tian J; Kovesdi I; Bruder JT
    J Gene Med; 2008 Feb; 10(2):123-31. PubMed ID: 18064718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter.
    Gill DR; Smyth SE; Goddard CA; Pringle IA; Higgins CF; Colledge WH; Hyde SC
    Gene Ther; 2001 Oct; 8(20):1539-46. PubMed ID: 11704814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrovirus-mediated gene therapy for hepatocellular carcinoma with reversely oriented therapeutic gene expression regulated by alpha-fetoprotein enhancer/promoter.
    Ishikawa H; Nakata K; Mawatari F; Ueki T; Tsuruta S; Ido A; Nakao K; Kato Y; Ishii N; Eguchi K
    Biochem Biophys Res Commun; 2001 Oct; 287(4):1034-40. PubMed ID: 11573968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno-associated virus (rAAV1) vector.
    Lu Y; Choi YK; Campbell-Thompson M; Li C; Tang Q; Crawford JM; Flotte TR; Song S
    J Gene Med; 2006 Jun; 8(6):730-5. PubMed ID: 16518879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of replication-defective adenovirus-vectored vaccines: protection following intramuscular injection is linked to promoter efficiency in muscle representative cells.
    Ambriović A; Adam M; Monteil M; Paulin D; Eloit M
    Virology; 1997 Nov; 238(2):327-35. PubMed ID: 9400605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.